日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

STRATEGIC-1: multiple-line, randomized, open-label GERCOR-PRODIGE-39 phase III trial in unresectable RAS/BRAF wild-type metastatic colorectal cancer

STRATEGIC-1:一项针对不可切除的 RAS/BRAF 野生型转移性结直肠癌的多线、随机、开放标签的 GERCOR-PRODIGE-39 III 期试验

Chibaudel, Benoist; Dourthe, Louis-Marie; André, Thierry; Henriques, Julie; Bourgeois, Vincent; Etienne, Pierre-Luc; Desramé, Jérôme; Carola, Elisabeth; Dupuis, Olivier; Baba-Hamed, Nabil; Auby, Dominique; Louvet, Christophe; Maillard, Emmanuel; Romano, Olivier; Tournigand, Christophe; Garcia-Larnicol, Marie-Line; Shacham-Shmueli, Einat; Bird, Brian Healey; Ghiringhelli, François; de Gramont, Aimery

Prognostic Impact of Blood Tumor Mutational Burden in pMMR/MSS Metastatic Colorectal Cancer Assessed by FoundationOne(®) Liquid CDx

FoundationOne® 液体 CDx 评估血液肿瘤突变负荷对 pMMR/MSS 转移性结直肠癌预后的影响

Chibaudel, Benoist; Carola, Elisabeth; Mekranter, Hamid; Goyer, Perrine; Saget, Arnaud; Oberlin, Olivier; Marijon, Hélène; Richa, Hubert; Iurisci, Ida; Gervais, Honorine; Perez-Staub, Nathalie; Dainese, Linda; Pujol, Pascal; Lamallem, Hanah; Besnard, Clémentine; Latrache, Sofya; Toledano, Alain; de Gramont, Aimery

Characteristics of Patients and Prognostic Factors Across Treatment Lines in Metastatic Colorectal Cancer: An Analysis From the Aide et Recherche en Cancérologie Digestive Database

转移性结直肠癌不同治疗线患者特征及预后因素:来自 Aide et Recherche en Cancérologie Digestive 数据库的分析

Bachet, Jean-Baptiste; de Gramont, Aimery; Raeisi, Morteza; Rakez, Manel; Goldberg, Richard M; Tebbutt, Niall C; Van Cutsem, Eric; Haller, Daniel G; Hecht, J Randolph; Mayer, Robert J; Lichtman, Stuart M; Benson, Al B; Sobrero, Alberto F; Tabernero, Josep; Adams, Richard; Zalcberg, John R; Grothey, Axel; Yoshino, Takayuki; André, Thierry; Shi, Qian; Chibaudel, Benoist

Interplay between sarcopenia, GDF-15, and the efficacy of nivolumab plus ipilimumab in patients with mismatch repair deficient metastatic colorectal cancer: final survival analysis of the phase II GERCOR NIPICOL study.

肌少症、GDF-15 与 nivolumab 加 ipilimumab 治疗错配修复缺陷型转移性结直肠癌患者的疗效之间的相互作用:II 期 GERCOR NIPICOL 研究的最终生存分析

Depotte Leonard, Nay Paula, Borg Christophe, Meurisse Aurélia, Henriques Julie, Bennouna Jaafar, De La Fouchardière Christelle, Tougeron David, Mazard Thibault, Chibaudel Benoist, Tournigand Christophe, Vernerey Dewi, Pigneur Frédéric, Andre Thierry, Cohen Romain

Sunitinib as Second-Line Treatment in Advanced Intrahepatic Cholangiocarcinoma: Results From the SUN-CK GERCOR Phase II Trial

舒尼替尼作为晚期肝内胆管癌二线治疗:SUN-CK GERCOR II期试验结果

Gros, Louis; Bouattour, Mohamed; Dumont, Clément; Dahan, Laëtitia; Malka, David; Tijeras-Raballand, Annemilaï; De Gramont, Armand; Ronot, Maxime; Dreyer, Chantal; Neuzillet, Cindy; Bourget, Philippe; Hadengue, Alexandra; Roldan, Nelly; Garcia-Larnicol, Marie-Line; Chibaudel, Benoist; Raymond, Eric; Faivre, Sandrine

Quantitative ctDNA Profiling of RAS Mutations as a Prognostic Biomarker in Metastatic Colorectal Cancer

定量ctDNA分析RAS突变作为转移性结直肠癌的预后生物标志物

Chibaudel, Benoist; Carola, Elisabeth; Mekranter, Hamid; Goyer, Perrine; Saget, Arnaud; Oberlin, Olivier; Marijon, Hélène; Richa, Hubert; Iurisci, Ida; Gervais, Honorine; Perez-Staub, Nathalie; Dainese, Linda; Pujol, Pascal; Toledano, Alain; Bachet, Jean-Baptiste; de Gramont, Aimery

The METACER national cohort study of brain metastases in gastrointestinal cancers prospectively establishes prognostic factors

METACER 全国性队列研究前瞻性地确定了胃肠道癌症脑转移的预后因素

Randrian, Violaine; Portales, Fabienne; Bouché, Olivier; Thezenas, Simon; Chibaudel, Benoist; Mabro, May; Terrebonne, Eric; Garnier-Tixidre, Claire; Louvet, Christophe; André, Thierry; Aparicio, Thomas; Dubreuil, Olivier; Bouché, Gregoire; Ychou, Marc; Tougeron, David

Circulating tumor DNA strongly predicts efficacy of chemotherapy plus immune checkpoint inhibitors in patients with advanced gastro-esophageal adenocarcinoma.

循环肿瘤DNA能够很好地预测晚期胃食管腺癌患者接受化疗联合免疫检查点抑制剂治疗的疗效

Tougeron David, Louvet Christophe, Desramé Jérôme, Evesque Ludovic, Angelergues Antoine, Carnot Aurélien, Breysacher Gilles, Zaanan Aziz, Etchepare Nicolas, Mabro May, Kaluzinski Laure, Petorin Caroline, Chibaudel Benoist, Aparicio Thomas, Bodere Anaïs, Rinaldi Yves, Le Malicot Karine, Emile Jean-François, Lepage Côme, Baures Aurélia, Djamai Hanane, Taly Valérie, Laurent-Puig Pierre

Assessment of the Addition of Oxaliplatin to Fluoropyrimidine-Based Adjuvant Chemotherapy in Patients With High-Risk Stage II Colon Cancer: An ACCENT Pooled Analysis

评估在以氟尿嘧啶为基础的辅助化疗中加入奥沙利铂治疗高危II期结肠癌患者的疗效:一项ACCENT汇总分析

Chibaudel, Benoist; Raeisi, Morteza; Cohen, Romain; Yothers, Greg; Goldberg, Richard M; Bachet, Jean-Baptiste; Wolmark, Norman; Yoshino, Takayuki; Schmoll, Hans-Joachim; Kerr, Rachel; Lonardi, Sara; George, Thomas J; Shacham-Shmueli, Einat; Shi, Qian; André, Thierry; de Gramont, Aimery

FOLFIRI Plus Durvalumab With or Without Tremelimumab in Second-Line Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: The PRODIGE 59-FFCD 1707-DURIGAST Randomized Clinical Trial

FOLFIRI联合度伐利尤单抗(加或不加曲美利木单抗)二线治疗晚期胃癌或胃食管交界处腺癌:PRODIGE 59-FFCD 1707-DURIGAST随机临床试验

Tougeron, David; Dahan, Laetitia; Evesque, Ludovic; Le Malicot, Karine; El Hajbi, Farid; Aparicio, Thomas; Bouché, Olivier; Bonichon Lamichhane, Nathalie; Chibaudel, Benoist; Angelergues, Antoine; Bodere, Anaïs; Phelip, Jean-Marc; Mabro, May; Kaluzinski, Laure; Petorin, Caroline; Breysacher, Gilles; Rinaldi, Yves; Zaanan, Aziz; Smith, Denis; Gouttebel, Marie-Claude; Perret, Clément; Etchepare, Nicolas; Emile, Jean-François; Sanfourche, Ivan; Di Fiore, Frédéric; Lepage, Côme; Artru, Pascal; Louvet, Christophe